Blum Robert I sold CYTK
September 14, 2026 · Form 4 insider transaction
Blum Robert I sold 7,500 shares of Cytokinetics, Incorporated at $73.44 per share, a transaction worth $550.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,500
Price
$73.44
Total value
$550.8K
InsiderBlum Robert I
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 14, 2026
Filing dateSeptember 15, 2026
Shares owned after377,820
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c).